The attention attracted by the AEBi story does a disservice to the many companies and researchers working diligently – and according to scientific standards – on treating cancer.
IMMUNOVATIVE STAFF perform quality control tests in the lab. (Photos: Courtesy)(photo credit: Courtesy)ByBRIAN BLUM
